Status:
COMPLETED
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
Lead Sponsor:
Mahidol University
Conditions:
Viral Conjunctivitis
Eligibility:
All Genders
7+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.
Detailed Description
The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 200...
Eligibility Criteria
Inclusion
- patients who were diagnosed with EKC at the outpatient ophthalmic unit
Exclusion
- children younger than six years
- women being pregnant or during lactation
- history of allergy to povidone-iodine
- prior ocular surgery
- contact lens usage and chronic eye diseases with current eye medications.
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT01179412
Start Date
July 1 2004
End Date
December 1 2009
Last Update
August 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Siriraj Hospital Mahidol University
Bangkoknoi, Bangkok, Thailand, 10700